Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response‐Based Approach-Reference-Cited by-同舟云学术

Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response‐Based Approach

Published:2020-05-27 Issue:1 Volume:72 Page:198-212
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Han Guohong¹^ORCID,Berhane Sarah²,Toyoda Hidenori³,Bettinger Dominik⁴^ORCID,Elshaarawy Omar⁵,Chan Anthony W. H.⁶^ORCID,Kirstein Martha⁷,Mosconi Cristina⁸,Hucke Florian⁹,Palmer Daniel¹⁰,Pinato David J.¹¹,Sharma Rohini¹¹,Ottaviani Diego¹²,Jang Jeong W.¹³^ORCID,Labeur Tim A.¹⁴,Delden Otto M.¹⁵,Pirisi Mario¹⁶,Stern Nick¹⁷,Sangro Bruno¹⁸,Meyer Tim¹⁹,Fateen Waleed²⁰²¹,García‐Fiñana Marta²,Gomaa Asmaa⁵,Waked Imam⁵,Rewisha Eman⁵,Aithal Guru P.²⁰²¹,Travis Simon²²,Kudo Masatoshi²³,Cucchetti Alessandro²⁴,Peck‐Radosavljevic Markus⁹,Takkenberg R.B.¹⁴,Chan Stephen L.²⁵,Vogel Arndt⁷,Johnson Philip J.¹⁰

Affiliation:

1. Department of Liver Disease and Digestive Interventional Radiology Xijing Hospital of Digestive Disease Fourth Military Medical University Xi’an China

2. Department of Biostatistics University of Liverpool Liverpool United Kingdom

3. Department of Gastroenterology and Hepatology Ogaki Municipal Hospital Ogaki Japan

4. Department of Medicine II Faculty of Medicine Medical Center University of Freiburg University of Freiburg Freiburg Germany

5. National Liver Institute Menoufia University Shebeen El‐Kom Egypt

6. Department of Pathology Chinese University of Hong Kong Hong Kong

7. Department of Gastroenterology, Hepatology and Endocrinology Hannover Medical School Hannover Germany

8. Radiology Unit Department of Specialized Diagnostic and Experimental Medicine Alma Mater Studiorum ‐ University of Bologna Italy University Hospital of Bologna Sant'Orsola‐Malpighi Polyclinic Bologna Italy

9. Department of Internal Medicine and Gastroenterology Klinikum Klagenfurt am Wörthersee Klagenfurt Austria

10. Department of Molecular and Clinical Cancer Medicine University of Liverpool Liverpool United Kingdom

11. Department of Surgery and Cancer Imperial College London London United Kingdom

12. UCL Cancer Institute University College London London United Kingdom

13. Department of Internal Medicine The Catholic University of Korea Seoul St. Mary’s Hospital Seoul Republic of Korea

14. Department of Gastroenterology and Hepatology Amsterdam University Medical Center Amsterdam the Netherlands

15. Department of Radiology Amsterdam University Medical Centers Amsterdam the Netherlands

16. Department of Translational Medicine Università del Piemonte Orientale Novara Italy

17. Department of Gastroenterology and Hepatology Aintree University Hospital Liverpool United Kingdom

18. Liver Unit Clínica Universidad de Navarra IDISNA and CIBEREHD Pamplona Spain

19. Research Department of Oncology UCL Cancer Institute University College London London United Kingdom

20. National Institute for Health Research Nottingham Biomedical Research Centre Nottingham University Hospitals National Health Service Trust and the University of Nottingham Nottingham United Kingdom

21. Nottingham Digestive Diseases Centre School of Medicine University of Nottingham Nottingham United Kingdom

22. Department of Radiology Nottingham University Hospitals National Health Service Trust Nottingham United Kingdom

23. Department of Gastroenterology and Hepatology Kinki University School of Medicine Osaka‐Sayama Osaka Japan

24. Department of Medical and Surgical Sciences University of Bologna Bologna Italy

25. Department of Clinical Oncology Chinese University of Hong Kong Shatin Hong Kong

Funder

National Institute for Health Research

National Natural Science Foundation of China

Engineering and Physical Sciences Research Council

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31022

Reference43 articles.

1. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

2. AASLD guidelines for the treatment of hepatocellular carcinoma

3. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

4. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

5. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study;JHEP Reports;2024-09

2. Evaluation of different scoring systems for repeating Transarterial Chemoembolization in Egyptian patients with Hepatocellular Carcinoma;Romanian Journal of Internal Medicine;2024-08-29

3. Predicting Survival Using Whole-Liver MRI Radiomics in Patients with Hepatocellular Carcinoma After TACE Refractoriness;CardioVascular and Interventional Radiology;2024-05-15

4. Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study;Clinical Cancer Research;2024-04-05

5. Construction of a prognostic model for hepatocellular carcinoma patients receiving transarterial chemoembolization treatment based on the Tumor Burden Score;BMC Cancer;2024-03-06